É-Conotoxins GVIA, MVIIA and CVID: SAR and Clinical Potential
Abstract: Highly selective N-type voltage-gated calcium (CaV) channel inhibitors from cone snail venom (the É-conotoxins) have emerged as a new class of therapeutics for the treatment of chronic and neuropathic pain. Earlier in 2005, Prialt (Elan) or synthetic É-conotoxin MVIIA, was the first ÃÂ...
Main Authors: | Richard J. Lewis, Christina I. Schroeder |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2006-04-01
|
Series: | Marine Drugs |
Subjects: | |
Online Access: | http://www.mdpi.com/1660-3397/4/3/193/ |
Similar Items
-
ω-Conotoxin GVIA Mimetics that Bind and Inhibit Neuronal Cav2.2 Ion Channels
by: Peter J. Duggan, et al.
Published: (2012-10-01) -
µ-Conotoxins Modulating Sodium Currents in Pain Perception and Transmission: A Therapeutic Potential
by: Elisabetta Tosti, et al.
Published: (2017-09-01) -
Conotoxins: Therapeutic Potential and Application
by: Richard T. Layer, et al.
Published: (2006-04-01) -
New Conotoxin SO-3 Targeting N-type Voltage-Sensitive Calcium Channels
by: Lei Wen, et al.
Published: (2006-04-01) -
Precursor Conotoxin Sequences From Conus Achatinus And Conus Monile
by: Dewan, Kalyan Kumar
Published: (2009)